AngioDynamics adds Lorinda Burgess to its Board of Directors

– USA, NY –  AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company, today announced the appointment of Lorinda Burgess to its Board of Directors, increasing the Board to nine members.

“Ms. Burgess’ impressive career has been marked by her ability to shape and execute transformative strategies that drive growth and remarkable profitability,. Her extensive track record of strong leadership and operational excellence adds to the collective expertise of our Board, and we are eager to benefit from her insights and guidance as we continue to execute our strategic investments and growth initiatives to become a profitable, high-growth medical technology company” said CEO, Jim Clemmer. 

About Lorinda Burgess

Lorinda Burgess brings over 35 years of management, financial, and global operations experience, including over 15 years at Medtronic, Inc., where she was responsible for the company’s Americas Region as CFO, and VP of Finance. While at Medtronic, Ms. Burgess led optimization initiatives that drove operational efficiencies and significant cost reductions.

Ms. Burgess was most recently CFO and VP of Finance for the Americas Region at Medtronic, Inc., a Fortune 200 global medical device company with more than $30 billion in annual revenues. Before this role, Ms. Burgess also served as VP of Customer Care for the Americas and Western Europe at Medtronic, Inc. and VP of Finance for the Cardiovascular Group’s Sales and Marketing function.

Ms. Burgess earned a Bachelor of Arts in Communication and Political Science from the University of Michigan and a Master’s in Business Administration from Ohio State University. Ms. Burgess is a member of the Board of Directors for Stepan Company.

About AngioDynamics, Inc.

AngioDynamics is a leading, and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs.

Source: https://www.angiodynamics.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.